InvestorsHub Logo
Followers 276
Posts 32701
Boards Moderated 0
Alias Born 11/14/2013

Re: john1045 post# 3672

Sunday, 01/26/2014 8:26:10 AM

Sunday, January 26, 2014 8:26:10 AM

Post# of 700553
Looks like he is working toward the DCVAX-L trial in Germany.

2009

Grant ($ 15,000) for a phase II/III study with dendritic cells in patients with stage IV Glioblastoma multiforme.



-- http://medical-center-cologne.com/robert-gorter_curriculum-vitae/

(It also appears in other cases he is augmenting dendritic therapy by adding Hyperthermia. This apparently means bringing the body to 42 degrees celcius or above -- which is 107 degrees farenheit!)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News